Yuya Kato During my master's degree, the theme was the development of tumor-specific CAR-T cell at Department of Immuno-Gene Therapy,Mie University Graduate School of Medicin,Mie,Japan. Development of Adenovirus vectors expressing multiplex guide RNAs of CRISPR/Cas9 at Institute of Microbial Chemistry,Tokyo,Japan. Currenyly at Reseach & Develpoment Division,kirin Holdings Company,Limited,Shonan Health Innovation Park,Kanagawa,Japan.